MOUNTAIN VIEW, Calif., March 11 /PRNewswire/ -- Based on its recent analysis of the radio-frequency identification (RFID) based biological delivery systems market, Frost & Sullivan recognizes Covidien with the 2008 North American Frost & Sullivan Product Innovation Award for developing a contrast delivery system with RFID technology. Covidien's contrast delivery system combines its unit-dose RFID enabled Ultraject(TM) prefilled contrast media syringes with its RFID enabled Optivantage(TM) dual head contrast delivery system to create a unique platform for contrast media administration in computed tomography (CT) imaging procedures.
Precise administration of contrast imaging agents to the patient is critical in radiology to help enhance the accuracy and efficiency of results obtained through the imaging process. The IMV Medical Information Division estimates that since 2003, there has been a 37 percent increase in the practice of CT, the key process that requires administration of contrast media; this is largely due to an increase in the number of CT scanners. The 2005 USP MEDMARX(R) report raised awareness of medication errors in radiology services (cardiac catheterization, radiology and nuclear medicine), which was more than six times higher compared to the general data set. In view of the alarming risk statistics, the challenge has been to develop an effective solution that would help enhance the accuracy of contrast agent administration and help in minimizing the risk, in effect.
"Covidien's innovative CT contrast delivery system with RFID enabled intelligence helps safeguard against certain life threatening medication errors," says Frost & Sullivan Research Analyst Bhuvaneashwar Subramanian. "The combined use of the RFID enabled Ultraject(TM) prefilled syr
|SOURCE Frost & Sullivan|
Copyright©2009 PR Newswire.
All rights reserved